B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

general

A B acute lymphoblastic leukemia that occurs during adulthood. It is characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.

73

Centers

130

Active Trials

$5.1B

Cancer Funding

Specific Cancer Types(1)

Top Centers for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1(73)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
65.2
2
NCI Comprehensive
Active Research Program
65.2
3
NCI Comprehensive
Active Research Program
65.2
4
NCI Comprehensive
Active Research Program
65.2
565.2
6
NCI Comprehensive
Active Research Program
65.2
7
NCI Clinical
Active Research Program
65.2
8
NCI Comprehensive
Active Research Program
65.2
9
Active Research Program
65.2
10
Active Research Program
65.2
11
NCI Clinical
Active Research Program
65.2
12
NCI Comprehensive
Active Research Program
65.2
13
Active Research Program
65.2
14
NCI Comprehensive
Active Research Program
65.2
15
Active Research Program
65.2
16
Active Research Program
65.2
17
Active Research Program
65.2
18
Active Research Program
65.2
19
Active Research Program
65.2
20
Active Research Program
65.2
21
NCI Comprehensive
Active Research Program
43.1
22
NCI Comprehensive
Active Research Program
43.1
23
NCI Comprehensive
Active Research Program
43.1
24
NCI Comprehensive
Active Research Program
43.1
25
NCI Comprehensive
Active Research Program
43.1
26
NCI Comprehensive
Active Research Program
43.1
27
NCI Comprehensive
Active Research Program
43.1
28
NCI Comprehensive
Active Research Program
43.1
29
NCI Comprehensive
Active Research Program
43.1
30
NCI Comprehensive
Active Research Program
43.1
31
NCI Comprehensive
Active Research Program
43.1
32
NCI Comprehensive
Active Research Program
43.1
33
NCI Comprehensive
Active Research Program
43.1
34
NCI Comprehensive
Active Research Program
43.1
35
NCI Comprehensive
Active Research Program
43.1
36
NCI Comprehensive
Active Research Program
43.1
37
NCI Clinical
Active Research Program
43.1
38
NCI Comprehensive
Active Research Program
43.1
39
NCI Comprehensive
Active Research Program
43.1
40
NCI Comprehensive
Active Research Program
43.1
41
NCI Comprehensive
Active Research Program
43.1
42
NCI Comprehensive
Active Research Program
43.1
43
NCI Comprehensive
Active Research Program
43.1
44
NCI Comprehensive
Active Research Program
43.1
45
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
43.1
46
NCI Clinical
Active Research Program
43.1
47
NCI Comprehensive
Active Research Program
43.1
4843.1
49
Active Research Program
43.1
50
Active Research Program
43.1
51
Active Research Program
43.1
52
Active Research Program
43.1
53
Active Research Program
43.1
54
Active Research Program
43.1
55
NCI Comprehensive
28.8
56
NCI Comprehensive
57
NCI Comprehensive
58
NCI Comprehensive
59
NCI Comprehensive
60
NCI Comprehensive
61
NCI Comprehensive
62
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
63
64
Cedars-Sinai CancerLos Angeles, CA
65
66
NCI Comprehensive
67
68
69
70
71
BC CancerVancouver, BC
72
73

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →